VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CORZCore Scientific, Inc.
$27.20$8.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCORZCash Flow

Core Scientific, Inc. (CORZ) Cash Flow Statement

7Y historyFree accessUpdated daily

Persistent negative free cash flow, highlighted by a $139.3M outflow in 2026Q1, underscores the company's heavy reliance on external capital to fund its ongoing infrastructure expansion.

CORZ Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Cash from Operations568.73M278.25M42.9M65.11M205.19M-56.73M-23.77M-832K
Operating CF Margin %-87.22%8.4%12.96%32.04%-10.42%-39.4%-1.4%
Operating CF Growth %6654.87%548.66%-34.12%-68.27%461.66%-138.73%-2756.37%-
Net Income-1.22B-288.62M-1.32B-246.49M-2.15B47.31M-12.21M-11.92M
Depreciation & Amortization66.32M68.91M120.12M96.44M226.09M33.36M9.4M6.12M
Stock-Based Compensation82.05M98.24M51.92M58.89M182.89M38.94M3.04M2.88M
Deferred Taxes0000-18.52M9.53M00
Other Non-Cash Items1.06B-124.82M1.21B-394.77M1.88B-136.36M-2.87M-3.59M
Working Capital Changes570.14M524.53M-27.64M551.03M78.61M-49.52M-21.13M5.68M
Change in Receivables10.1M0659K-744K-7.58M-7.41M-1.55M-83K
Change in Inventory00000000
Change in Payables30.95M10.78M-12.27M118.6M26.71M-21.99M-1.77M0
Cash from Investing-1.03B-740.75M-95.19M-3M-590.78M-423.84M-15.14M-37.36M
Capital Expenditures-1.03B-729M-94.96M-16.16M-601.66M-59.27M-1.57M-37.41M
CapEx % of Revenue290.32%228.51%18.6%3.22%93.96%10.89%2.6%62.85%
Acquisitions2.63M00010.85M-365.21M-13.67M0
Investments--------
Other Investing-6.71M-6.75M-231K13.16M-10.82M645K92K52K
Cash from Financing912.48M-63.1M819.57M-44.65M306.15M603.53M40.72M28.69M
Debt Issued (Net)959.69M-10.29M766.91M-40.99M117.74M613.7M38.08M-832K
Equity Issued (Net)5.61M6.91M55M0-31.65M671.26M00
Dividends Paid00000000
Share Repurchases0000-31.65M000
Other Financing-52.82M-59.73M-2.34M-3.66M220.06M-681.43M2.64M29.53M
Net Change in Cash366.67M-525.6M767.27M17.47M-79.44M122.96M1.81M-9.5M
Free Cash Flow-471.2M-450.75M-52.06M48.95M-396.47M-116.01M-25.33M-38.24M
FCF Margin %-132.83%-141.29%-10.2%9.74%-61.92%-21.31%-42%-64.25%
FCF Growth %-175.17%-765.74%-206.36%112.35%-241.75%-357.94%33.76%-
FCF per Share-1.46-1.42-0.200.13-1.16-0.50-0.07-0.10
FCF Conversion (FCF/Net Income)0.39x-0.96x-0.03x-0.26x-0.10x-1.20x1.95x0.07x
Interest Paid7.38M00086.01M38.18M2.9M0
Taxes Paid204K0005.76M9.62M00

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Capital intensive infrastructure requirements

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Disconnect

As reported in recent financial statements, the divergence between net income and operating cash flow is stark, with 2026Q1 showing a net loss of $347.2M against $249.9M in operating cash flow, highlighting the heavy reliance on non-cash adjustments to reconcile the company's actual liquidity position.

The persistent gap between accounting losses and operating cash flow suggests that non-cash charges, likely related to asset impairments or depreciation, are significantly distorting the bottom line. Investors should monitor whether this cash flow generation is sustainable or merely a byproduct of aggressive accounting treatments that mask the underlying operational burn.

Negative Free Cash Flow Trajectory

Based on quarterly filings, Core Scientific has consistently posted negative free cash flow, with a $139.3M outflow in 2026Q1, indicating that the company's capital-intensive infrastructure expansion continues to outpace its ability to generate self-sustaining cash from its core digital asset mining and hosting operations.

The inability to achieve positive free cash flow despite revenue growth suggests that the company remains in a capital-intensive growth phase that requires constant external funding. This trajectory warrants further investigation into whether the current infrastructure investments will eventually yield the promised high-margin returns or continue to drain liquidity.

Capital Intensity and Asset Replacement

According to SEC filings, Core Scientific's capital expenditure reached $389.3M in 2026Q1, representing a significant commitment to hardware and infrastructure that underscores the company's vulnerability to the rapid obsolescence of mining equipment and the high costs associated with maintaining its energized power capacity.

The high level of capital intensity relative to revenue suggests that a substantial portion of cash is being funneled into maintenance and growth capex just to remain competitive in a difficult mining environment. This reliance on continuous reinvestment may limit the company's flexibility to pivot toward more stable hosting services without further dilutive financing.

Working Capital Volatility and Management

As evidenced by the $62.2M working capital inflow in 2026Q1, Core Scientific's cash flow is heavily influenced by fluctuations in current assets and liabilities, which often serve as a temporary buffer against the company's underlying operational losses and high fixed-cost structure.

The volatility in working capital changes suggests that the company may be managing its payables or inventory levels to artificially smooth out cash flow metrics. Analysts should be cautious, as these shifts are often transitory and do not represent a fundamental improvement in the company's core cash-generating efficiency.

CORZ — Frequently Asked Questions

Quick answers to the most common questions about buying CORZ stock.

How much cash does Core Scientific, Inc. (CORZ) generate from operations?

Core Scientific, Inc. (CORZ) generated $278.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Core Scientific, Inc.'s free cash flow?

Core Scientific, Inc. (CORZ) reported negative free cash flow of $450.8M in 2025, indicating capital requirements exceeded cash from operations.

What is Core Scientific, Inc.'s capital expenditure (CapEx)?

Core Scientific, Inc. (CORZ) spent $729.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.